Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Degradation of a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) compound in different environments.
Lyshtva P, Voronova V, Barbir J, Leal Filho W, Kröger SD, Witt G, Miksch L, Sabowski R, Gutow L, Frank C, Emmerstorfer-Augustin A, Agustin-Salazar S, Cerruti P, Santagata G, Stagnaro P, D'Arrigo C, Vignolo M, Krång AS, Strömberg E, Lehtinen L, Annunen V. Lyshtva P, et al. Among authors: d arrigo c. Heliyon. 2024 Jan 24;10(3):e24770. doi: 10.1016/j.heliyon.2024.e24770. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322905 Free PMC article.
Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.
Zaakouk M, Van Bockstal M, Galant C, Callagy G, Provenzano E, Hunt R, D'Arrigo C, Badr NM, O'Sullivan B, Starczynski J, Tanchel B, Mir Y, Lewis P, Shaaban AM. Zaakouk M, et al. Among authors: d arrigo c. Cancers (Basel). 2023 Feb 28;15(5):1511. doi: 10.3390/cancers15051511. Cancers (Basel). 2023. PMID: 36900303 Free PMC article.
Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC).
Dobritoiu F, Baltan A, Chefani A, Billingham K, Chenard MP, Vaziri R, Lacroix-Triki M, Waydelich A, Erb G, Andersson E, Cañamero M, Toro P, Wedden S, D'Arrigo C. Dobritoiu F, et al. Among authors: d arrigo c. Appl Immunohistochem Mol Morphol. 2022 Sep 1;30(8):549-556. doi: 10.1097/PAI.0000000000001053. Epub 2022 Aug 23. Appl Immunohistochem Mol Morphol. 2022. PMID: 36036647 Free PMC article.
Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect.
Pece R, Tavella S, Costa D, Varesano S, Camodeca C, Cuffaro D, Nuti E, Rossello A, Alfano M, D'Arrigo C, Galante D, Ravetti JL, Gobbi M, Tosetti F, Poggi A, Zocchi MR. Pece R, et al. Among authors: d arrigo c. Haematologica. 2022 Apr 1;107(4):909-920. doi: 10.3324/haematol.2021.278469. Haematologica. 2022. PMID: 34109776 Free PMC article.
142 results